Evidence map

ReviewCurrent diabetes reviews2024

Empagliflozin-A Sodium Glucose Co-transporter-2 Inhibitor: Overview ofits Chemistry, Pharmacology, and Toxicology.

Jyoti Yadav et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 38265382